ATE491023T1 - Neuer phosphorylierungsstandort für mitogenaktivierte proteinkinasen und modifizierte proteine sowie anwendungen davon - Google Patents

Neuer phosphorylierungsstandort für mitogenaktivierte proteinkinasen und modifizierte proteine sowie anwendungen davon

Info

Publication number
ATE491023T1
ATE491023T1 AT06818202T AT06818202T ATE491023T1 AT E491023 T1 ATE491023 T1 AT E491023T1 AT 06818202 T AT06818202 T AT 06818202T AT 06818202 T AT06818202 T AT 06818202T AT E491023 T1 ATE491023 T1 AT E491023T1
Authority
AT
Austria
Prior art keywords
mitogen
phosphorylation site
applications
protein kinases
activated protein
Prior art date
Application number
AT06818202T
Other languages
English (en)
Inventor
Montesinos Cristina Murga
Menendez Federico Mayor
Pueyo Maria Jurado
Muelas Pedro Manuel Campo
Pedrique Sandra Peregrin
Original Assignee
Univ Madrid Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Madrid Autonoma filed Critical Univ Madrid Autonoma
Application granted granted Critical
Publication of ATE491023T1 publication Critical patent/ATE491023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AT06818202T 2005-06-10 2006-06-09 Neuer phosphorylierungsstandort für mitogenaktivierte proteinkinasen und modifizierte proteine sowie anwendungen davon ATE491023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200501404 2005-06-10
PCT/EP2006/005542 WO2007028430A1 (en) 2005-06-10 2006-06-09 New phosphorylation site of mitogen-activated protein kinases, modified proteins and applications

Publications (1)

Publication Number Publication Date
ATE491023T1 true ATE491023T1 (de) 2010-12-15

Family

ID=37074555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06818202T ATE491023T1 (de) 2005-06-10 2006-06-09 Neuer phosphorylierungsstandort für mitogenaktivierte proteinkinasen und modifizierte proteine sowie anwendungen davon

Country Status (15)

Country Link
US (1) US20080233097A1 (de)
EP (1) EP1899461B1 (de)
JP (1) JP2008545434A (de)
KR (1) KR20080023729A (de)
CN (1) CN101233228A (de)
AT (1) ATE491023T1 (de)
AU (1) AU2006289476A1 (de)
BR (1) BRPI0611598A2 (de)
CA (1) CA2611191A1 (de)
DE (1) DE602006018735D1 (de)
ES (1) ES2357681T3 (de)
IL (1) IL187969A0 (de)
MX (1) MX2007015702A (de)
RU (1) RU2008100039A (de)
WO (1) WO2007028430A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2324083B1 (es) * 2007-10-22 2010-05-31 Consejo Superior De Investigaciones Cientificas Procedimiento para el diagnostico y tratamiento de enfermedades que cursan con alteracion de la quinasa p38, elementos necesarios para llevarlo a cabo y sus aplicaciones.
WO2010060972A1 (en) * 2008-11-26 2010-06-03 Julius-Maximilians-Universitaet Wuerzburg Erk1/2 phosphorylation site specific antibody
CN101608184B (zh) * 2009-04-03 2010-12-01 山东农业大学 棉花促丝裂原活化蛋白激酶基因GhMAPK16的克隆及其应用
US20120252737A1 (en) * 2009-10-02 2012-10-04 Massachusetts Institute Of Technology Methods for Diagnosing and Treating Cancer
CA2856030A1 (en) 2011-11-16 2013-05-23 Duke University Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction
US20230149430A1 (en) * 2020-04-06 2023-05-18 Duke University Compositions and methods for the treatment of infection-induced cardiomyopathy
CN111521817B (zh) * 2020-04-24 2022-03-01 首都医科大学附属北京胸科医院 一种用于识别蛋白质磷酸化位点的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU686669B2 (en) * 1993-09-17 1998-02-12 Smithkline Beecham Corporation Drug binding protein
EP1355157A1 (de) * 2001-12-24 2003-10-22 Institut National De La Sante Et De La Recherche Medicale (Inserm) FADD Proteine, phosphorylierte p38-MAPK und FasL als Tumormarker

Also Published As

Publication number Publication date
KR20080023729A (ko) 2008-03-14
EP1899461B1 (de) 2010-12-08
WO2007028430A1 (en) 2007-03-15
IL187969A0 (en) 2008-03-20
CN101233228A (zh) 2008-07-30
RU2008100039A (ru) 2009-07-20
JP2008545434A (ja) 2008-12-18
DE602006018735D1 (de) 2011-01-20
EP1899461A1 (de) 2008-03-19
CA2611191A1 (en) 2007-03-15
US20080233097A1 (en) 2008-09-25
ES2357681T3 (es) 2011-04-28
MX2007015702A (es) 2008-04-22
BRPI0611598A2 (pt) 2010-09-21
AU2006289476A1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
UA94582C2 (ru) Генетическая модификация mon89788 сои и способы ее определения
BRPI0513897A (pt) diferenciação de células-tronco
IL187969A0 (en) New phosphorylation site of mitogen-activated protein kinases, modified proteins and applications
TW200637547A (en) Compounds and compositions as protein kinase inhibitors
CO6602158A2 (es) Derivados de piperidin-4-il azetidina como inhibidores de jak1
BRPI0719797A8 (pt) Compostos e composições como inibidores de proteína cinase
BRPI0808888B8 (pt) composto de fenil amino pirimidina para uso no tratamento de uma doença associada à quinase, processo para a preparação do composto, composição farmacêutica, e, implante
BR112012015721A2 (pt) modificação covalente de proteínas dirigida por ligante
EP3926045C0 (de) Mutante proteine und verfahren zur auswahl davon
ATE528989T1 (de) Kristalline feste rasagilin-base
UY31952A (es) 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
CY1116970T1 (el) Fkbp-l και χρησεις αυτων ως αναστολεις αγγειογενεσης
MY144044A (en) Compounds and compositions as protein kinase inhibitors
CR20130668A (es) Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
EA201000146A1 (ru) Связующее майларда на основе гидроксимонокарбоновой кислоты
EP2365750A4 (de) Benzoxazol-kinasehemmer und verfahren zu ihrer verwendung
NI201100063A (es) Inhibidores de las enzimas de proteína cinasa activadas por mitógeno p38.
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
NZ596571A (en) Pyrazolopyrimidines and related heterocycles as kinase inhibitors
MX2012003101A (es) Derivados de pirimidina como inhibidores de la proteina tirosina quinasa 2.
EA020703B9 (ru) Пиразолохиназолины
BRPI0615270A2 (pt) pirazol fundido como inibidores de p38 map cinase
BRPI0810719A8 (pt) Inibidores da enzima diacilglicerol o-acetiltansferase tipo 1
ATE477321T1 (de) Aviäre telomerase reverse transkriptase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties